DigestRedComo funciona
Red
/
Empresas
Gu
No verificado

Guardant Health, Inc.

Sobre qué escribimos

BiotecnologíaIndustriaOncologíaSaludSanidad

115 Comunicados de prensa

Ver todos los comunicados de prensa
30/04/2026
Mercado laboral
Industria
Oncología
Salud
Medicina - Varios
Farmacéutica
Biotecnología
Guardant Health Announces Multi-Year Strategic Collaboration with Nuvalent to Develop Companion Diagnostics and Support Potential Commercialization of Targeted Cancer Therapies Using the Guardant Infinity™ Platform
Fuente
Guardant Health, Inc.
Editor
Business Wire
1.00
0
29/04/2026
Web y redes sociales
Eventos
Ferias y Congresos
Biotecnología
Farmacéutica
Salud
Oncología
Guardant Health to Participate in Upcoming Investor Conferences
Fuente
Guardant Health, Inc.
Editor
Business Wire
1.00
0
16/04/2026
Web y redes sociales
Telefonía
Finanzas
Mercado de valores
Biotecnología
Material médico sanitario
Salud
Oncología
Guardant Health to Report First Quarter 2026 Financial Results on May 7, 2026
Fuente
Guardant Health, Inc.
Editor
Business Wire
1.00
0
30/03/2026
Industria
Oncología
Salud
Técnica
Medicina - Varios
Farmacéutica
Guardant Health’s InfinityAI Real-World Evidence Supports Approval of ENHERTU® for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in Japan
Fuente
Guardant Health, Inc.
Editor
Business Wire
1.00
0
18/03/2026
Eventos
Industria
Biotecnología
Salud
Farmacéutica
Oncología
Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026
Fuente
Guardant Health, Inc.
Editor
Business Wire
1.00
0
16/03/2026
Técnica
Higiene alimentaria
Asociaciones/Profesionales
Salud
Oncología
Software
Seguros
Finanzas
Mercado laboral
Industria
Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership
Fuente
Guardant Health, Inc.
Editor
Business Wire
1.00
0
13/03/2026
Análisis de Mercados
Industria
Oncología
Salud
Biotecnología
Sanidad
New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare
Fuente
Guardant Health, Inc.
Editor
Business Wire
1.00
0
10/03/2026
Mercado laboral
Industria
Oncología
Salud
Sanidad
Gestión empresarial
Biotecnología
Guardant Health’s Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics
Fuente
Guardant Health, Inc.
Editor
Business Wire
1.00
0
04/03/2026
Guardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities Across America
Fuente
Guardant Health, Inc.
Editor
Business Wire
1.00
0
03/03/2026
Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened
Fuente
Guardant Health, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0